Transcriptional analyses identify genes that modulate bovine macrophage response to Toxoplasma infection and immune stimulation by Gossner, Anton & Hassan, Musa
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Transcriptional analyses identify genes that modulate bovine
macrophage response to Toxoplasma infection and immune
stimulation
Citation for published version:
Gossner, A & Hassan, M 2020, 'Transcriptional analyses identify genes that modulate bovine macrophage
response to Toxoplasma infection and immune stimulation', Frontiers in Cellular and Infection Microbiology.
https://doi.org/10.3389/fcimb.2020.00437
Digital Object Identifier (DOI):
10.3389/fcimb.2020.00437
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Frontiers in Cellular and Infection Microbiology
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 22. Sep. 2020
ORIGINAL RESEARCH
published: 20 August 2020
doi: 10.3389/fcimb.2020.00437
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 1 August 2020 | Volume 10 | Article 437
Edited by:
Prajwal Gurung,
The University of Iowa, United States
Reviewed by:
David Arranz-Solís,
University of California, Davis,
United States
Xiaoyu Hu,
University of Texas Southwestern
Medical Center, United States
*Correspondence:
Musa A. Hassan
musa.hassan@roslin.ed.ac.uk
Specialty section:
This article was submitted to
Microbes and Innate Immunity,
a section of the journal
Frontiers in Cellular and Infection
Microbiology
Received: 27 April 2020
Accepted: 16 July 2020
Published: 20 August 2020
Citation:
Gossner A and Hassan MA (2020)
Transcriptional Analyses Identify
Genes That Modulate Bovine
Macrophage Response to
Toxoplasma Infection and Immune
Stimulation.
Front. Cell. Infect. Microbiol. 10:437.
doi: 10.3389/fcimb.2020.00437
Transcriptional Analyses Identify
Genes That Modulate Bovine
Macrophage Response to
Toxoplasma Infection and Immune
Stimulation
Anton Gossner 1 and Musa A. Hassan 1,2*
1Division of Infection and Immunity, The Roslin Institute, The University of Edinburgh, Edinburgh, United Kingdom, 2Centre
for Tropical Livestock Genetics and Health, The University of Edinburgh, Edinburgh, United Kingdom
The obligate intracellular parasite, Toxoplasma gondii, is highly prevalent among livestock
species. Although cattle are generally resistant to Toxoplasma strains circulating in
Europe and North America, the underlying mechanisms are largely unknown. Here,
we report that bovine bone marrow-derived macrophage (BMDM) pre-stimulated with
interferon gamma (IFNγ) restricts intracellular Toxoplasma growth independently of nitric
oxide. While Toxoplasma promoted the expression of genes associated with alternative
macrophage activation and lipid metabolism, IFNγ abrogated parasite-induced
transcriptional responses and promoted the expression of genes linked to the classical
macrophage activation phenotype. Additionally, several chemokines, including CCL22,
that are linked to parasite-induced activation of the Wnt/β-catenin signaling were
highly expressed in Toxoplasma-exposed naïve BMDMs. A chemical Wnt/β-catenin
signaling pathway antagonist (IWR-1-endo) significantly reduced intracellular parasite
burden in naïve BMDMs, suggesting that Toxoplasma activates this pathway to
evade bovine macrophage anti-parasitic responses. Congruently, intracellular burden
of a mutant Toxoplasma strain (RH1ASP5) that does not secrete dense granule
proteins into the host cell, which is an essential requirement for parasite-induced
activation of the Wnt/β-catenin pathway, was significantly reduced in naïve BMDMs.
However, both the Wnt/β-catenin antagonist and RHASP15 did not abolish parasite
burden differences in naïve and IFNγ-stimulated BMDMs. Finally, we observed that
parasites infecting IFNγ-stimulated BMDMs largely express genes associated with
the slow dividing bradyzoite stage. Overall, this study provides novel insights into
bovine macrophage transcriptional response to Toxoplasma. It establishes a foundation
for a mechanistic analysis IFNγ-induced bovine anti-Toxoplasma responses and the
counteracting Toxoplasma survival strategies.
Keywords: bovine toxoplasmosis, macrophages, RNA-sequencing, Toxoplasma, chemokine, Wnt/β-catenin-
signaling
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INTRODUCTION
Toxoplasma is a zoonotic protozoan parasite that infects virtually
all warm-blooded vertebrates and is perhaps the most successful
and widespread human pathogen. It is the leading cause of
encephalitis and death in HIV/AIDS patients (Basavaraju, 2016)
and is ranked 4th among foodborne parasites with the greatest
global impact (FAO/WHO, 2014) and contributors to years
lived with disability and disability-adjusted life years per million
persons (Gkogka et al., 2011). Toxoplasma undergoes sexual
reproduction exclusively in cats while asexual reproduction can
occur in any intermediate host, including humans and farmed
animals. Definitive-to-intermediate host parasite transmission
occurs via ingestion of oocysts from infected cat feces, while
transmission between intermediate hosts can occur through the
consumption of contaminated food products or vertically from
mother to fetus (Hill and Dubey, 2002). Although Toxoplasma
infections in healthy individuals are mostly asymptomatic, severe
disease or even death, often caused by damage to the brain or
other organs, can occur in immunocompromised or congenitally
infected individuals (Hill andDubey, 2002).Toxoplasma typically
establishes lifelong chronic infection in healthy intermediate
hosts by encysting, after an initial phase of rapid intracellular
proliferation and cell–cell spread, in the central nervous system
and muscle tissues (Hill and Dubey, 2002). To do this, the
parasite must carefully regulate immune activation and host cell
anti-Toxoplasma effector mechanisms.
Toxoplasma invades host cells mostly through an active
process powered by parasite-generated actin motor activity to
form a specialized non-fusogenic parasitophorous vacuole (PV)
(Fleckenstein et al., 2012) that helps the parasite avoid host
cell immune surveillance (Morisaki et al., 1995). In phagocytic
cells, such as macrophages, the parasite can also be taken
up by phagocytosis and, sometimes the phagocytosed parasites
can exit the phagosome to form a PV (Zhao et al., 2014).
Besides hiding within the PV, the parasite also evades host cell
immunity by sequentially discharging several effector proteins
that modulate a variety of host immune and metabolic processes,
including the inflammatory pathway (Hunter and Sibley,
2012). Generally, effective host anti-Toxoplasma responses are
dependent on the production of interleukin (IL)-12 (Gazzinelli
et al., 1994) by macrophages and dendritic cells (Gazzinelli
et al., 1994). IL-12 in turn activates natural killer (NK)
and T cells to secrete interferon gamma (IFNγ) (Gazzinelli
et al., 1993, 1994), a pro-inflammatory cytokine that activates
several anti-Toxoplasma effector mechanisms such as the
interferon-regulated GTPases (IRGs) in mice (Zhao et al., 2009),
reactive nitrogen/oxygen intermediates (Scharton-Kersten et al.,
1997), tryptophan degradation and cell death in human cells
(Pfefferkorn, 1984; Niedelman et al., 2013), and inflammasome
activation (Cirelli et al., 2014). In return, Toxoplasma has
evolved several mechanisms to counteract the IFNγ-induced
host defenses, including the secretion of effectors proteins
from specialized apical organelles that co-opt host transcription
and signaling pathways to control host cell responsiveness to
inflammatory signals (Jensen et al., 2011; Koshy et al., 2012;
Bougdour et al., 2013; He et al., 2018).
Besides producing the IL12 that primes IFNγ secretion by
NK and T cells, macrophages are also the preferred intracellular
niche for the fast-dividing parasite stage (Jensen et al., 2011).
Thus, the innate defenses triggered by monocytes/macrophages
are key to toxoplasmosis pathogenesis in humans and rodents
(Channon et al., 2000; Dunay and Sibley, 2010; Gregg et al.,
2013; Tosh et al., 2016; Song et al., 2017). Besides killing
microbes, including Toxoplasma, macrophages can also initiate
adaptive immune responses (van de Vosse et al., 2009; Thi
et al., 2012). Human and mouse models show that upon
the engagement of surface signaling receptors or pattern
recognition receptors (PRRs) such as, toll-like (TLRs), RIG-
I-like (RLRs), and the cytosolic NOD-like (NLRs) receptors
by conserved pathogen-associated molecular patterns (PAMPs)
such as, lipopolysaccharide (LPS) or immune factors, including
cytokines, macrophages assume different activation phenotypes.
The most extreme classical [M1, M(IFNγ)] and the alternative
[M2, M (IL-4)] phenotypes are separated by several intermediate
activation states (Murray et al., 2014). The M1 phenotype,
which can be induced by IFNγ, is highly microbicidal and
characterized by the production of reactive oxygen and nitrogen
intermediates such as nitric oxide (NO), and a range of pro-
inflammatory cytokines and chemokines, such as Tumor necrosis
factor (TNF) alpha (De Paoli et al., 2014; Murray et al., 2014). In
contrast, the M2 phenotype, which is induced by IL-4 and IL-
13 and is important for regulating inflammation, is characterized
by the production of anti-inflammatory cytokines and growth
factors (Sindrilaru and Scharffetter-Kochanek, 2013). The general
hypothesis is that macrophage activation phenotypes, which
are underpinned by discrete transcriptional programs (Hassan
et al., 2015), provide a high degree of plasticity that is exploited
by some intracellular pathogens, including Toxoplasma and
Mycobacteria, to turn this potentially hostile host cell into a
favorable replication niche (Price and Vance, 2014). Although
effective host response to Toxoplasma require the induction of
inflammation, characterized by classical macrophage activation,
Toxoplasma promotes its survival in macrophages by secreting
effector proteins to dampen inflammatory responses and favor
alternative macrophage activation (Jensen et al., 2011). Indeed,
Toxoplasma strain differences in virulence inmice is partly due to
strain differences in inducing alternative macrophage activation
(Jensen et al., 2011), while host differences in susceptibility
to Toxoplasma is due in part to differences in macrophage
activation phenotypes after infection (Jensen et al., 2011, 2013).
Therefore, to devise strategies to improve the early defense
against Toxoplasma and a variety of intracellular pathogens,
it is important to understand the molecular mechanisms
underpinning macrophage response to Toxoplasma and/or
immune effector proteins, such as cytokines.
Toxoplasma is common in many species of livestock,
including cattle. Compared to other livestock species, such as
sheep and pigs, cattle are highly resistant to Toxoplasma and
rarely transmit the parasite to other intermediate hosts (Dubey,
1986; Esteban-Redondo and Innes, 1997). Unlike sheep and pigs,
natural Toxoplasma infection in cattle is mostly asymptomatic
and does not appear to result in abortion. However, themolecular
factors and mechanisms that modulate bovine-Toxoplasma
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interactions, which can be exploited to enhance resistance in
other ruminants, are ambiguous. Although IFNγ is central to
anti-Toxoplasma responses in virtually all vertebrates, the role
of this cytokine, and the mechanism underpinning, bovine
resistance to Toxoplasma is equivocal. In the present study we
sought to determine the role of IFNγ, and host genes associated
with effective bovine macrophage response to Toxoplasma. We
performed RNA-sequencing on naïve or IFNγ-stimulated bovine
bone marrow derived macrophages (BMDMs) that were either
unexposed or exposed to a Toxoplasma strain that is highly
virulent in laboratory inbred mice (RH) for 24 h. Analysis
of the datasets provides novel insights into the Toxoplasma-
induced transcriptional responses in naïve and pre-stimulated
BMDMs. We report that IFNγ enhances bovine BMDMs
anti-Toxoplasma responses and that, despite producing large
amounts of nitric oxide, bovinemacrophages restrict Toxoplasma
independently of nitric oxide. Toxoplasma induces the Wnt/β-
catenin signaling pathway and the expression of several anti-
inflammatory chemokines and arginine metabolism in naïve
BMDMs. On the other hand, to survive in IFNγ-primed BMDMs,
the parasite expresses mostly genes that are associated with its
slow dividing bradyzoite stage.
MATERIALS AND METHODS
Parasites
The type I Toxoplasma strain (RH) engineered to express green
fluorescent protein (GFP) and firefly luciferase has previously
been described (Jensen et al., 2013). The RH1ASP5 (Hammoudi
et al., 2015) was a generous gift from Dr. Mohamed-Ali Hakimi
(INSERM). All parasite strains were maintained by serial passage
on confluent human foreskin fibroblast (HFF) monolayer.
Primary Bone Marrow Derived
Macrophages (BMDMs)
Marrow cells were flushed from the ribs of three (n = 3)
∼2 year old calves using phosphate buffered saline (PBS,
Invitrogen). The cells were centrifuged at 500 × g for
5min at 4◦C and re-suspended in red cell lysis buffer
(Sigma) and incubated on ice for 5min. Next, the cells
were passed through a 70µm cell strainer (BD Biosciences)
and centrifuged at 500 × g for 5min at 4◦C. Cells from
each calf were subsequently differentiated into macrophages
in 10 cm non-tissue culture petri dishes (Corning) in RPMI
1640 (Sigma-Aldrich) supplemented with heat-inactivated 20%
fetal bovine serum (FBS, Thermo Fisher Scientific), GlutaMAX
(Thermo Fisher Scientific), penicillin/streptomycin (Thermo
Fisher Scientific), and recombinant humanCSF1 (104 U/ml; a gift
from Chiron, Emeryville, CA) for 10 days as previously described
(Young et al., 2018).
In vitro Measurements
BMDMs from each calf were detached using a cell scraper,
washed, counted, and seeded separately in triplicates in 96-
well plates at a density of 105 cells/well. The BMDMs were left
unstimulated (naïve) or stimulated with: recombinant bovine
IFNγ (100 ng/mL), lipopolysaccharide (LPS) from Salmonella
enterica serotype Minnesota Re 595 (Sigma-Aldrich, 100 ng/mL),
or a combination of IFNγ (100 ng/mL) and LPS (100 ng/mL)
with or without aminoguanidine (final concentration of 500µM)
and incubated at 37◦C in 5% CO2. 24 h post-stimulation, cell
free supernatants were collected for Griess reagent-based nitric
oxide assay, as previously described (Young et al., 2018), and
cell viability, using the CellTiter 96 R© Aqueous One Solution
Cell Proliferation kit (Promega) according to the manufacturer’s
recommendations. Freshly lysed parasites (by sequential passage
through 25G and 27G needles) were passed through a 5µm
filter to remove HFFs, counted, diluted in RPMI, and added
to the BMDMs at a multiplicity of infection (MOI) 1 for 24 h
before luciferase activity was measured using a luciferase assay
kit (Promega) according to the manufacturer recommendations.
RNA Sequencing and Analysis
2 × 106 BMDMs from each calf were seeded in 6-well plates and
left unstimulated or stimulated with IFNγ (100 ng/mL) for∼18 h
at 37◦C in 5% CO2. Next, the media was replaced with fresh
media containing Toxoplasma at a MOI 1 and incubated further
for ∼18 h. Fresh media was added to the non-infected control
BMDMs. At the end of the incubation period, total RNA was
isolated from each BMDM sample using QIAzol R© Lysis Reagent
and miRNeasy Mini Kit (Qiagen) according to the manufacturer
recommendations. RNA quality and integrity were assessed on
the Agilent 2200 TapeStation using an Agilent RNA ScreenTape
and quantified using aQubit RNABRAssay Kit and Fluorometer.
RNA-seq libraries were generated and sequenced by Edinburgh
Genomics. All libraries were prepared using the Illumina TruSeq
Stranded library protocol for total RNA libraries (Part: 15031048,
Revision E). Briefly, polyA-tail enrichment (Dynabeads mRNA
Purification Kit; Invitrogen) was performed on the total RNA
and the mRNA fragmented into 200–400 base-pairs, and reverse
transcribed into cDNA before Illumina sequencing adapters were
added to each end. Twelve barcoded libraries were multiplexed
and sequenced on a single S2 sequencing lane on the Illumina
NovaSeq 6000 machine to yield ∼60 million 50 bp high
quality strand-specific paired reads per sample. Reads were
pseudoaligned to the Ensembl bovine genome (ARS-UCD1.2)
using Kallisto v.0.46.0 (Bray et al., 2016) with 100 bootstraps
to generate transcript-level expression estimates as transcripts
per million (TPM) as previously described (Young et al., 2018).
Gene-level differential expression analysis was performed in
sleuth as previously described (Pimentel et al., 2017). TPM values
derived from pseudoalignment of RNA-seq reads to the GT1
genome (ToxoDB.org) were used as input in sleuth to identify
differentially expressed Toxoplasma genes.
Quantitative Real-Time PCR
One microgram of total RNA from each BMDMs sample
was reverse transcribed using Superscript III (Thermo Fisher
Scientific), 10mM dNTP mix (Thermo Fisher Scientific) and
Oligo (dT)12−18 Primer (Thermo Fisher Scientific) according to
the manufacturer’s instructions. Gene-specific primers (Table 1)
were designed using Primer-BLAST (Ye et al., 2012). All primers
were commercially synthesized by Thermo Fischer Scientific.
Quantitative real-time RT-PCR (qPCR) was performed in a
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TABLE 1 | Primer sets for qPCR validation of representative differentially
expressed genes.
Symbol Primer 1 forward Primer 1 reverse Amplicon
length
C1R GGTGCAGGATCAAGGACTGC GTGTGCATCTTGTAGAAGGGCT 136
ISG15 GACCTGACGGTGAAGATGCTA ATCTTCTGGGCGATGAACTGC 98
PSMB8 TGTCAATATGTACCACAT
GAAGGAG
CACCATCACTGACTGGCCTC 102
SGK1 GCCAAGGATGACTTTATGGAGA AGGATCAAAGTGTCGCAGG 138
IRF1 AGGACATCATGAAGCTCTTGGA GCTCCTCCTTGCAACTGAACT 129
GBP5 CCAGGAAAGGAATACAGGCTGA TTCCATTGCTGTGAGAGCCAG 107
RSAD2 GTGGTTCCAGAAGTACGGTGA CTTCTTTCCTTGACCACGGC 103
CFB CTTGCAAAGGTGATTCTGGTGG CGCTTGCAAACATCCACGAC 100
GBP1 CTCTCAAACTGCAGGAACAGTC TGCTTTGGATAAGAGT
GACCAG
175
CXCL10 TCCTCGAACACGGAAAGA
GGCATA
AGCTGATATGGTGACTGG
CTTGGT
164
CCL22 CGGGACTACATCCGTTACCC CAGCACAGATCTCTCGGTCC 121
CCl24 GCAGGAGTGATCTTCACCACC TAGCGGAGGCTTTCTTCTGC 115
SDHA ACCTGATGCTTTGTGCTCTGC CCTGGATGGGCTTGGAGTAA 126
GAPDH GGTGATGCTGGTGCTGAGTA TCATAAGTCCCTCCACGATG 265
Rotor-Gene Q real-time PCR cycler (Qiagen) using FastStart
Universal SYBR Green Master (Rox) in final volume of 20
µL. The linearity and efficiency of qPCR amplification was
determined for each primer pair using a standard curve generated
by a serial dilution of cDNA pooled from all the samples. All
reactions were performed in duplicate and “no template” controls
included for each gene. Agarose gel electrophoresis was used
to confirm product sizes and melt curve analysis confirmed
specificity of amplification. Data were analyzed using the 2−11Ct
method and statistical analyzed performed on the 1Ct values.
qPCR was performed on parasite DNA as previously described
(Li et al., 2000).
RESULTS
IFNγ Induces Restriction of Toxoplasma
Growth in Bovine Macrophages
Independently of Nitric Oxide
To determine whether IFNγ is essential for the control of
Toxoplasma growth in bovine macrophages, we exposed naïve
or IFNγ-stimulated bovine bone marrow-derived macrophages
(BMDMs) to a luciferase-expressing type I Toxoplasma strain
(RH) for 24 h and measured luciferase activity, a proxy for
parasite burden (Hassan et al., 2015). In murine macrophages,
IFNγ is known to require a second stimulant, such as LPS
or TNF, to effectively restrict Toxoplasma (Sibley et al., 1991;
Hassan et al., 2015). Therefore, we included in our experiments,
BMDMs that were pre-stimulated with IFNγ+LPS. As expected,
there was reduced intracellular parasite burden in BMDMs pre-
stimulated with IFNγ or IFNγ+LPS, relative to naïve BMDMs
(Figure 1A). However, there were no significant differences
in parasite burden between IFNγ- and IFNγ+LPS-stimulated
BMDMs, suggesting that IFNγ alone can sufficiently induce
anti-Toxoplasma activities in bovine BMDMs. A quantitative
real-time polymerase chain reaction (qRT-PCR) analysis of
parasite DNA (Li et al., 2000) confirmed the intracellular parasite
burden differences between naïve and IFNγ-stimulated BMDMs
(Figure 1B).
Previously, others and we reported that Nitric oxide (NO),
a product of the inducible nitric oxide synthase (iNOS or
NOS2)-catalyzed L-arginine metabolism (MacMicking et al.,
1997), is a major IFNγ-induced effector against intracellular
Toxoplasma growth in murine BMDMs (Hassan et al., 2015).
In addition, bovine BMDMs stimulated with LPS and/or IFNγ
are reported to produce significantly more NO than ovine
or equine BMDMs (Denis et al., 2005; Young et al., 2018),
which are susceptible to Toxoplasma. Thus, we postulated that
NO inhibits Toxoplasma growth in bovine IFNγ-stimulated
BMDMs. Consequently, we determined whether IFNγ alone
can induce NO production in bovine BMDMs and whether the
levels of the induced NO correlate with intracellular parasite
burden in the pre-stimulated BMDMs. Unlike IFNγ, IFNγ+LPS
induced a 34-fold increase in NO, relative to unstimulated
BMDMs (Figure 1C). Thus, unlike murine BMDMs, NO is
dispensable for IFNγ-induced Toxoplasma growth restriction in
bovine BMDMs.
Toxoplasma Induces a Robust Bovine
Macrophage Transcriptional Response
To gain mechanistic insight into bovine innate immune response
to Toxoplasma, we leveraged high throughput RNA-sequencing
to profile the transcriptional landscape of bovine BMDMs that
were left unstimulated (naïve) or pre-stimulated with IFNγ
before being exposed to Toxoplasma for 24 h. Transcriptional
analysis was also performed on uninfected controls. Downstream
analysis was restricted to genes that were differentially expressed
by more than 2-fold change and had at least 10 reads that
uniquely aligned to the genome in at least two samples when
compared the uninfected naïve BMDMs. In total, 1,349 unique
genes were differential expressed in at least one condition, of
which 887 were differentially expressed in a condition-specific
manner (Figure 2A and Supplementary Table 1). Unlike IFNγ
that interacts mainly with the IFNγ receptors to induce the
expression of several IFNγ-specific genes (ISGs), Toxoplasma is
likely to interact with many, yet to be defined, bovine BMDM
pattern recognition receptors to induce bovine gene expression.
Indeed, there were more differentially expressed genes that were
unique to naïve BMDMs exposed to Toxoplasma (RH-specific)
than in the uninfected IFNγ-stimulated BMDMs, (657 vs. 134,
respectively; Hypergeometric P-value ≤ 0.05). Interestingly, only
96 genes were differentially expressed exclusively in IFNγ-
stimulated BMDMs exposed to Toxoplasma (IRH-specific),
suggesting that pre-stimulation with IFNγ abrogates a majority
of Toxoplasma-induced transcriptional changes in the BMDMs
(Figure 2A). The variable expression of most genes (579/657,
∼88%), including immunoregulatory genes such as Krüppel-like
factor 4 (KLF4) and Ornithine decarboxylase (ODC1), in the
RH BMDMs was due to increased transcript abundance in the
Toxoplasma-exposed BMDMs, rather than a downregulation of
innately expressed genes, as revealed by hierarchical clustering
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FIGURE 1 | IFNγ restricts Toxoplasma growth in bovine bone marrow derived macrophages (BMDMs) independently of inducible nitric oxide. (A) Bovine BMDMs
stimulated with IFNγ (100 ng/mL) and/or LPS (100 ng/mL) for ∼18 h have reduced intracellular parasite burden, relative to control, which did not change with the
addition of aminoguanidine (AG), a scavenger for reactive oxygen/nitrogen species, to the cell culture medium. (B) Reduced intracellular parasite burden in
IFNγ-simulated BMDMs was confirmed using a quantitative real-time PCR (qPCR) on parasite DNA as previously described (Li et al., 2000). (C) Similar to murine,
BMDMs, IFNγ alone, without a second stimulant, does not sufficiently induce NO in bovine BMDMs. Data are average value ±s.d. of three replicates. P-values of
two-tailed unpaired Student’s t-test; *p < 0.05 and ns = not significant. Data are representative of three independent experiments.
(Figure 2B), suggesting that effective response to the parasite
is inducible. Three hundred and forty genes, including several
inflammatory cytokines such C-X-C motif chemokine ligand
10 (CXCL10) that were differentially expressed in unexposed
IFNγ-stimulated BMDMs, remained dysregulated by a similar
fold-change magnitude when the IFNγ-stimulated BMDMs were
exposed to Toxoplasma (IRH), suggesting an inability by the
parasite to overcome most of the IFNγ-induced transcriptional
changes. Arginase 2 (ARG2) was among 13 genes that were
highly expressed in RH but downregulated in IFNγ-stimulated
BMDMs. Similarly, 60 genes, including the C-Cmotif chemokine
22 (CCL22), were upregulated in RH but downregulated by
a difference of more than 2-fold change between in RH and
IRH BMDMs.
To gain greater insights into the biological processes
underpinning bovine BMDMs transcriptional response to
Toxoplasma, and to determine whether the transcriptional
changes in the different BMDM conditions was due to differences
in the induction of distinct gene sets or the magnitude of
induction of the same gene sets, we performed a pre-ranked
gene set enrichment analysis (GSEA) (Subramanian et al., 2005)
on the differentially expressed genes in IFNγ-stimulated, IRH,
and RH BMDMs using the curated “HALLMARK” gene set
database (Liberzon et al., 2015). Several “HALLMARK” gene
sets, including the interferon gamma response, inflammatory
response, and the regulation of cytokine production, were
significantly (FDR ≤ 0.05) enriched in at least two BMDM
conditions. Some gene sets, including hypoxia, which is not
only a well-established Toxoplasma-induced host cell response,
but also supports intracellular parasite growth (Wiley et al.,
2010), were significantly enriched in RH but absent in IRH
(Figure 2C). Thus, infection of naïve and IFNγ-stimulated
BMDMsmodulated by differences in the induction of unique and
common gene sets.
IFNγ Reverses Toxoplasma-Induced
Dysregulation of Genes Linked to
Inflammatory and Metabolic Pathways to
Restrict Parasite Replication in Bovine
Macrophages
As demonstrated above, Toxoplasma significantly dysregulate
several bovine genes, potentially to support its intracellular
survival. We reasoned that since IFNγ-stimulated BMDMs
are refractory to the parasite, Toxoplasma-induced genes that
support the intracellular parasite lifestyle are likely to be targeted
and reversed when BMDMs are pre-stimulated with IFNγ prior
to infection. Several inflammatory genes were dysregulated in
IRH but not in RH BMDMs. For example, CXCL9, 10, and 11,
were 22-, 10-, and 12-fold, respectively, upregulated in IRH, but
not dysregulated in RH, BMDMs. Markers for the Toxoplasma-
refractory classically activated macrophages, such as CD180,
CD74, and CD1D were highly expressed in IRH but not in
RH BMDMs. Similarly, c-type lectins including CLEC6A, which
are associated with classically activated macrophages (Jensen
et al., 2011; Murray et al., 2014), were upregulated in IRH
BMDMs. Conversely, calcium signaling genes that are reported
to play a significant role in intracellular parasite survival, such
as CAMK2G, and histone deacetylase (HDAC) 5, and 7, were
downregulated in RH, but remained unchanged in IRH BMDMs.
A functional analysis on genes upregulated or unchanged in
IRH BMDMs revealed an enrichment for, among others, calcium
signaling pathway, phospholipase D signaling, defense response
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FIGURE 2 | Distinct changes in gene expression underpin bovine macrophage response to IFNγ and/or Toxoplasma. (A) RNA-seq analysis of bovine BMDMs that
were either left unstimulated and uninfected (Control), unstimulated and infected (RH), or stimulated with IFNγ (100 ng/mL) and uninfected (IFNγ) or stimulated with
IFNγ and infected (IRH). Venn diagram representation of the number of dysregulated genes (≥2-fold; ≥10 uniquely aligned reads) relative to the control BMDMs. (B)
Heatmap representation of genes dysregulated in RH BMDMs shows most of the stochastic changes in gene expression was due was due to Toxoplasma-induced
increase in transcript abundance. (C) Enrichment analysis in the HALLMARK gene sets of the differentially expressed genes shows that Toxoplasma induced a unique
gene sets, including the Myc targets V1 and V2.
to virus, and positive regulation of I-κβ kinase/NFκβ signaling
(Figure 3A).
Genes implicated in chemotaxis or anti-inflammatory
responses were differentially expressed by a margin of more
than 2-fold change between RH and IRH BMDMs. For example,
chemotaxis-related CCL22 and CCL24 chemokines were
upregulated by 20- and 12-fold in RH but upregulated by 14-
and 8-fold in IRH BMDMs. Similarly, the chemokine receptor
(CCR7) was upregulated by 26-fold in RH but not differentially
expressed in IRH BMDMs. The anti-inflammatory-related
suppressor of cytokine signaling (SOCS) 3, and TNF receptor-
associated factor 1 (TRAF1) were also upregulated in RH but
downregulated in IRH BMDMs. Mitogen-activated protein
kinases (MAPK), including MAP3K14 and MAP4K1, which
induce non-canonical (Jin et al., 2014) and suppresses canonical
(Brenner et al., 2005) NF-κB signaling pathways, respectively,
were upregulated in RH but downregulated in IRH BMDMs.
Studies in model animals, including mice, have shown that
Toxoplasma induces alternative macrophage activation to favor
its intracellular lifestyle (Melo et al., 2011). Arginine metabolism,
via arginase, is key to alternative macrophage activation.
Congruently, Arginase 2 (ARG2) was 4-fold upregulated in RH
but virtually not expressed in IRH BMDMs. Additional genes
associated with alternative macrophage activation, such as KLF4
and IL34 were upregulated in RH but downregulated in IRH
BMDMs. The expression of protein arginine methyltransferase
5 (PRMT5), which is necessary in c-MYC-mediated alternative
macrophage differentiation, was slightly increased in RH
BMDMs. Similarly, genes encoding glucose transporters were
upregulated in RH but not IRH BMDMs. Solute carriers (SLC),
including SLC2A1 and SLC2A3 that encode glucose transporters,
were downregulated in IRH but upregulated in RH BMDMs.
Other solute carriers, including SLC7A1 and SLC7A5 that
function in the L-arginine transport pathway, and ODC1, the
rate limiting enzyme in polyamine biosynthesis and a negative
regulator of macrophage inflammation (Hardbower et al.,
2017), were upregulated in RH BMDMs. Toxoplasma reportedly
rely on host lipid droplets, which increase in abundance
in Toxoplasma-infected cells, to sustain rapid intracellular
replication (Gomes et al., 2014). The expression of pentraxin
3 (PTX3), which is induced by lipid accumulation (Liu et al.,
2014), was increased 8-fold in RH but unexpressed in IRH
BMDMs. Similarly, the expression of genes involved in fatty acid
elongation, such as ELOVL6, were upregulated in RH but not
expressed in IRH BMDMs. Genes upregulated in RH but not
IRH BMDMs were significantly (FDR ≤ 0.05) linked to purine
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FIGURE 3 | Dysregulated genes in RH and IRH are enriched in unique and common functional terms. Enrichment analysis in functional annotation and gene ontology
(GO) analysis of the differentially expressed genes using metascape show that enrichment for unique functional terms in (A) Genes upregulated and/or unchanged IRH
BMDMs, and (B) Genes upregulated in RH but not IRH BMDMs. (C) A subset of differentially expressed genes were validated in quantitative real-time polymerase
chain reaction (qPCR) in naïve infected (RH), IFNγ-stimulated and infected (IRH), and IFNγ-stimulated BMDMs. Data are average value ±s.d. of three replicates.
P-values of two-tailed unpaired Student’s t-test; ***p < 0.001. Data are representative of two independent experiments.
metabolism, NIK/NFκβ (non-canonical NFκβ) signaling, and
regulation of apoptotic signaling pathway (Figure 3B), all of
which are expected to play a role in regulating Toxoplasma’s
intracellular fate (Yamamoto et al., 2011; Blume and Seeber,
2018). Quantitative RT-PCR (qPCR) confirmed the differential
expression of genes, including CXCL10, CCL22, and CCL24
that are reportedly upregulated in Toxoplasma-infected murine
macrophages (Melo et al., 2013), in the different macrophage
conditions (Figure 3C and Supplementary Figure 1). Thus,
IFNγ targets both the host cell inflammatory and metabolic
pathways to revoke intracellular parasite replication.
IFNγ Abrogates Toxoplasma-Induced
Wnt/β-Catenin Signaling in Bovine
Macrophages
Recent studies have documented Toxoplasma-induced
expression of several chemokines, including CCL17, CCL22,
and CCL24 (He et al., 2018; Majumdar et al., 2019) via the
activation of the Wnt/β-catenin signaling pathway (He et al.,
2018).Wnt/β-catenin-signaling has an important role in various
cellular processes, including proliferation (Reya et al., 2003) and
immunity (Staal et al., 2008). The variable expression of CCL22
and CCL24, in RH and IRH BMDMs, prompted us to investigate
the expression of Wnt-target genes to establish a role of Wnt/β-
catenin signaling in bovine BMDM response to Toxoplasma.
However, apart from the downregulation of delta like canonical
Notch ligand 1 (DLL1) in IFNγ-stimulated BMDMs, none of the
canonical Wnt-target genes were differentially expressed in RH
and/or IRH BMDMs.
Unlike Toxoplasma, IFNγ is known to suppress Wnt/β-
catenin signaling (Nava et al., 2014; Bai et al., 2017). To
determine whether Toxoplasma growth restriction in IFNγ-
stimulated bovine BMDMs is linked toWnt/β-catenin signaling,
we evaluated parasite burden in naïve or IFNγ-stimulated
BMDMs cultured in the presence or absence of a Wnt/β-
catenin antagonist (IWR-1-endo). IWR-1-endo reduced parasite
burden in naïve BMDMs in a dose-dependent manner without
abolishing the differences in parasite burden between naïve
and IFNγ-stimulated BMDMs (Figure 4A).Toxoplasma-induced
accumulation of β-catenin in the host cell nucleus, and the
dysregulation of CCL22 is reportedly induced by a dense granule
(GRA) protein (GRA18) that is secreted beyond the parasites’
parasitophorous vacuole membrane (PVM) into the host cell
during infection (He et al., 2018). Thus, to overcome the potential
effect of IWR-1-endo on unrelated host cell functions and
establish a direct link between infection and Wnt/β-catenin
activation, we infected naïve or IFNγ-stimulated BMDMs with
a mutant Toxoplasma strain (RH1ASP5) and quantified parasite
burden using qPCR. The RH1ASP5mutant strain lacks the ASP5
enzyme that is essential for the processing of GRA proteins,
including GRA18, that are destined for secretion into the host
cell (Coffey et al., 2015; Hammoudi et al., 2015; Curt-Varesano
et al., 2016; He et al., 2018). We reasoned that if GRAs that
are secreted in the host cell interact with β-catenin to induce
chemokine secretion and support intracellular parasite survival
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and replication in bovine BMDMs, then the RH1ASP5 strain
should not be able to replicate efficiently in naïve BMDMs.
Indeed, parasite burden was significantly reduced in naïve
BMDMs infected with RH1ASP5, relative to the wildtype
(Figure 4B). Unlike wildtype parasites, IWR-1-endo did not
significantly alter parasite burden in naïve or IFNγ-stimulated
BMDMs infected with RH1ASP5 (Figure 4C). Neither did
IWR-1-endo abrogate intracellular RH1ASP5 burden differences
between naïve and IFNγ-stimulated BMDMs. Finally, when
infected with RH1ASP5, but not the wildtype parental strain,
naïve BMDMs exhibited high abundance for CCL22 transcripts
(Figure 4D). Together, these results indicate a role for Wnt/β-
catenin signaling and parasite secreted GRAs that translocate to
the host cell in bovine BMDMs anti-Toxoplasma responses.
Parasites in IFNγ-Stimulated Bovine
Macrophages Transcribe Mostly
Bradyzoite-Related Genes
To evaluate whether the infection of bovine BMDMs is
underpinned by distinct parasite expression signatures, we used
the RNA-sequencing reads uniquely aligning to the parasite
genome (GT1 v.46) to evaluate stochastic changes in Toxoplasma
transcript abundance in naïve and IFNγ-stimulated BMDMs.We
focused our analysis on genes that were modulated by more
than 3-fold change and had more than 10 uniquely aligned
RNA-sequencing reads in at least two samples when comparing
parasites infecting naïve and IFNγ-stimulated BMDMs. One
hundred and eighty one genes were differentially expressed,
of which 94 corresponded to genes upregulated in IFNγ-
stimulated BMDMs (Figure 5 and Supplementary Table 1).
Parasite genes that were highly expressed when the parasite is
in IFNγ-stimulated BMDMs included DnaK-tetratricopeptide
repeat (DnaK-TPR) and Cyclic AMP-Dependent Protein Kinase
Subunit 3 (cAMPK3), which are associated with or involved
in stress-induced Toxoplasma stage conversion from the fast
dividing tachyzoite to the semi-dominant bradyzoite parasite
stage (Ueno et al., 2011; Sugi et al., 2016). Thus, consistent
with the well-defined immune pressure-induced parasite stage
conversion, Toxoplasma potentially responds to the IFNγ-
induced immune pressure by slowing down its rate of replication.
DISCUSSION
The outcome of Toxoplasma infections in cattle is fundamentally
different from that of rodents, small ruminants, and pigs: clinical
disease in naturally infected cattle are rare and many large-
scale studies have failed to detect viable parasites in bovine
tissues (Stelzer et al., 2019), suggesting that, like humans, cattle
are largely an end-stage host for the parasite. However, the
mechanisms underlying bovine resistance to Toxoplasma are
largely unknown. In this study, we performed high throughput
functional genomics and parasitological assays to investigate
the molecular factors that modulate Toxoplasma interactions
with bovine bone marrow-derived macrophages (BMDMs).
Similar to observations in rodent and human macrophages,
interferon gamma (IFNγ) significantly enhanced intracellular
parasite growth restriction in bovine BMDMs. Interestingly,
despite the ability to restrict intracellular parasite growth, IFNγ
on its own was not able to induce nitric oxide (NO) secretion
in bovine BMDMs, indicating that, unlike murine BMDMs,
IFNγ-induced toxoplasmastatic activities in bovine BMDMs are
independent of NO. Additionally, we found that secreted parasite
dense granule proteins potentially induce the expression of
chemokines, including CCL22, to enhance parasite growth in
naïve bovine BMDMs.
Understanding the mechanisms of innate recognition and
response to Toxoplasma in mice has been invaluable in
advancing knowledge on response to Toxoplasma in other
vertebrates, including cattle. The IFNγ-induced murine anti-
Toxoplasma effectors, which are largely dependent on the
activation of immunity-related GTPases (IRGs) and guanylate
binding proteins (GBPs), are well-characterized. However, cattle,
like humans, lack functional toll-like receptor (TLR) 11 and 12
(O’Neill et al., 2013) that facilitate the recognition ofToxoplasma-
derived pathogen-associated molecular patterns (PAMPs) in
murine cells (Melo et al., 2010). Although bovine BMDMs
express a functional TLR5, unlike murine TLR5, it does not
recognize Toxoplasma antigens (Tombácz et al., 2018). Thus,
the mechanisms by which bovine cells recognize and respond
to Toxoplasma are equivocal and potentially different from
those defined in the murine system. Previous studies, including
our own (Jensen et al., 2013; Hassan et al., 2015), show
that reactive oxygen and nitrogen species, including NO, are
central to Toxoplasma growth inhibition in murine macrophages
synergistically activated with IFNγ and LPS or TNF. Bovine
macrophages are known to secrete significantly more NO in
response to LPS than sheep and pigs, which are susceptible
to Toxoplasma, LPS (Jungi et al., 1996; Young et al., 2018),
suggesting that species-specific differences in susceptibility to
Toxoplasma is due to differences in NO production. Although
parasite growth was significantly restricted in stimulating bovine
BMDMs with IFNγ-stimulated bovine BMDMs, IFNγ, on it’s
own, did not induce NO in bovine BMDMs, which is consistent
with previous observations (Denis et al., 2005; Young et al.,
2018; Imrie and Williams, 2019). In fact, intracellular parasite
burden in IFNγ- and IFNγ+LPS-stimulated BMDMs were
similar, despite the latter secreting significantly more NO.
Combined, these results suggest that NO is dispensable in IFNγ-
induced bovine BMDM toxoplasmastatic activities. A similar
non-essential role for NO inmacrophage response toToxoplasma
has previously been observed in human macrophages. However,
humanmacrophages are distinct from bovine BMDMs, since NO
cannot be induced by conventional activating regimes in vitro in
human macrophages (Schneemann and Schoedon, 2002).
Recent studies have documented a role for Wnt/β-
catenin signaling in host responses to Toxoplasma. Enhanced
intracellular Toxoplasma growth was found to co-occur with
increased β-catenin (CTNNB1) gene expression in human
cells (Majumdar et al., 2019), while a parasite secreted GRA
protein is reported to stabilize β-catenin in murine BMDMs
leading to an increased expression of chemokines such as
CCL22 (He et al., 2018; Majumdar et al., 2019). Consistent
with IFNγ-induced inhibition of the Wnt/β-catenin signaling
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FIGURE 4 | A role for Wnt/β-catenin signaling in the IFNγ-induced response to Toxoplasma in bovine macrophages. (A) Naïve (white bars) or IFNγ-stimulated (black
bars) were cultured overnight with or without increasing concentrations of the Wnt/β-catenin signaling antagonist IWR-1-endo and infected with a parental wildtype
(RHTy3) Toxoplasma strains. IWR-1-endo did not abolish differences in intracellular parasite burden between naïve and IFNγ-stimulated BMDMs. (B) The growth of the
knockout RH1ASP5 parasite strain was significantly inhibited in naïve BMDMs infected, relative to the wildtype. RH1ASP5 parasites do not secrete most dense
granule proteins, including GRA18, beyond the parasitophorous vacuole membrane. (C) Unlike wildtype parasites, IWR-1-endo did not significantly alter parasite
burden in naïve or IFNγ-stimulated BMDMs infected with RH1ASP5. (D) The parental RHTy3 strain induced significantly higher expression of CCL22 in naïve BMDMs
when compared to the knockout RH1ASP5 strain. Data are average value ±s.d. of three replicates. P-values of two-tailed unpaired Student’s t-test; *p < 0.05,
***p < 0.001 and ns = not significant. Data are representative of three independent experiments.
pathway (Nava et al., 2014; Bai et al., 2017), we observed a
downregulation of several Wnt/β-catenin signaling-associated
genes, including CCL17, CCL22, and CCL24 (He et al., 2018),
in IFNγ-stimulated BMDMs. Congruently, a Wnt/β-catenin
signaling chemical inhibitor (IWR-1-endo) reduced intracellular
parasite burden in naïve BMDMs in a dose-dependent manner.
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 9 August 2020 | Volume 10 | Article 437
Gossner and Hassan Bovine Macrophage Response to Toxoplasma
FIGURE 5 | Toxoplasma gene expression varies in naïve and stimulate bovine macrophage. Heatmap representation of the differentially expressed genes (≥3-fold;
≥10 uniquely aligned reads in at least two samples) between parasites in naïve (RH) and IFNγ-stimulated (IRH) BMDMs.
However, IWR-1-endo did not abolish intracellular parasite
burden differences between naïve and IFNγ-stimulated BMDMs,
probably because IFNγ suppresses Wnt/β-catenin signaling to
a level below which further inhibition produces no discernible
effect. Considering that we used a single IFNγ concentration
(100 ng/mL), it is plausible that IWR-1-endo would have
an effect at lower IFNγ concentrations. A more plausible
explanation for the lack of IWR-1-endo efficacy in IFNγ-
stimulated cells is that besides the Wnt/β-catenin signaling,
IFNγ induces additional effector mechanisms against the
parasite. Although GRA18 is reported to induce β-catenin
accumulation in the host cell nucleus, this was not discernible
when GRA18 was expressed at physiological levels (He et al.,
2018), which may partly explain the lack of β-catenin nuclear
accumulation in the present study. Nevertheless, intracellular
parasite burden in bovine BMDMs infected with a mutant
Toxoplasma strain that does not secrete GRA18 into the host
cell cytoplasm (RH1ASP5) (He et al., 2018), was significantly
different from cells infected the wildtype parasites. Similar
to IWR-1-endo, infection with RH1ASP5 did not abolish
intracellular parasite burden differences between naïve and
IFNγ-stimulated BMDMs.
The mechanisms regulating the impact of Wnt/β-catenin on
intracellular Toxoplasma replication are largely equivocal. Recent
studies indicate that β-catenin alters intracellular parasite growth
dynamics by interacting with indoleamine 2,3-dioxygenase 1
(IDO1): IDO1 promoter activity is supported by β-catenin.
IDO1 is an IFNγ-inducible protein that degrades tryptophan
to kynurenine and is known to impede Toxoplasma growth in
human fibroblasts (Pfefferkorn, 1984), epithelial, and endothelial
cells (MacKenzie et al., 2007) in vitro. Because IDO1 degrades
tryptophan, which supports intracellular Toxoplasma replication,
increased IDO1 promoter activity in the presence of β-
catenin may appear contradictory. However, IDO1 transcript
and protein levels are often discordant in Toxoplasma-infected
cells: Toxoplasma promotes the degradation of IDO1 protein
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(Majumdar et al., 2019). Although we cannot conclude, from this
study, that tryptophan plays an essential role in bovine BMDM
response to Toxoplasma, IDO1 was significantly downregulated
in naïve BMDMs exposed toToxoplasma. In the absence of IDO1,
tryptophan is catabolized to melatonin, which scavenges reactive
oxygen species (ROS) and promotes cell survival (Dolado and
Nebreda, 2008), both of which are beneficial for intracellular
Toxoplasma survival. However, considering that NO and ROS
are dispensable for Toxoplasma growth restriction in bovine
BMDMs, scavenging of ROS is unlikely to be a viable mechanism
by which β-catenin can affect parasite replication. Rather, it
is plausible that melatonin promotes cell survival, which in
turn promotes intracellular parasite survival. Indeed, we did
not observe significant changes in cell viability in Toxoplasma-
infected, relative to uninfected, BMDMs. Alternatively, Wnt/β-
catenin-mediated anti-Toxoplasma mechanisms may involve
the induction of alternative macrophage activation, which is
supportive of intracellular Toxoplasma survival and growth
(Melo et al., 2011). Besides, the expression of Wnt/β-catenin-
associated chemokines, we observed increased expression
of genes associated with alternatively activated or foamy
macrophages, such as KLF4, ARG2, ODC1, and PTX3, in
naïve, but not IFNγ-stimulated, BMDMs. Combined, with the
increased expression of glucose transporters in naïve BMDMs,
which is reversed in IFNγ-stimulated BMDMs, we conclude that
Toxoplasma exploits the bovine BMDMs metabolic pathways to
enhance intracellular survival and replication. It is worth noting
that we have tested only one clonal parasite strain (RH) at a
single MOI and that different Toxoplasma strains, including
the genetically distinct atypical strains such as GUYDOS, and
higher MOIs may induce significantly different responses in the
bovine BMDMs.
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